loader
Please Wait
Applying Filters...

Approved Marketing Authorisations (MA) containing NCGC00024853-02 in Europe. Original Data : EMA Website

Menu
$ API Ref.Price (USD/KG) : 143Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Abbott Laboratories

02 2TEOFARMA Srl

03 3THERABEL GIENNE PHARMA SpA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

levosulpiride

Brand Name : Levopraid

Dosage Form :

Dosage Strength : 20 Cpr 25 Mg  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

02

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

levosulpiride

Brand Name : Levopraid

Dosage Form :

Dosage Strength : Gtt Os 20 Ml 2.5%  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

03

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

levosulpiride

Brand Name : Levopraid 50

Dosage Form :

Dosage Strength : 20 Cpr 50 Mg  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

04

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

levosulpiride

Brand Name : Levopraid 100

Dosage Form :

Dosage Strength : 20 Cpr 100 Mg  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

05

TEOFARMA Srl

Country
Boulder Peptide 2024
Not Confirmed
arrow

TEOFARMA Srl

Country
arrow
Boulder Peptide 2024
Not Confirmed

levosulpiride

Brand Name : Lopraid

Dosage Form : Levosulpiride 25Mg 6 Units Parenteral Use

Dosage Strength : 6 VIALS IM EV 25 mg 2 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

THERABEL GIENNE PHARMA SpA

Country
Boulder Peptide 2024
Not Confirmed
arrow

THERABEL GIENNE PHARMA SpA

Country
arrow
Boulder Peptide 2024
Not Confirmed

levosulpiride

Brand Name : Lobren

Dosage Form : Levosulpiride 25Mg 6 Units Parenteral Use

Dosage Strength : 6 VIALS IM EV 2 ml 12.5 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

TEOFARMA Srl

Country
Boulder Peptide 2024
Not Confirmed
arrow

TEOFARMA Srl

Country
arrow
Boulder Peptide 2024
Not Confirmed

levosulpiride

Brand Name : Lopraid

Dosage Form : Levosulpiride 50Mg 6 Units Parenteral Use

Dosage Strength : 6 VIALS IM EV 50 mg 2 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

08

THERABEL GIENNE PHARMA SpA

Country
Boulder Peptide 2024
Not Confirmed
arrow

THERABEL GIENNE PHARMA SpA

Country
arrow
Boulder Peptide 2024
Not Confirmed

levosulpiride

Brand Name : Levobren

Dosage Form :

Dosage Strength : 20 Cpr 25 Mg  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

09

THERABEL GIENNE PHARMA SpA

Country
Boulder Peptide 2024
Not Confirmed
arrow

THERABEL GIENNE PHARMA SpA

Country
arrow
Boulder Peptide 2024
Not Confirmed

levosulpiride

Brand Name : Levobren

Dosage Form :

Dosage Strength : Gtt Os 20 Ml 2.5%  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank